Stay in touch
We'd love to keep in touch about news, events and how you can get involved. To hear from us, please sign up below.
We answer some common questions about the current COVID-19 vaccines and breast cancer treatments.
The Isle of Pink is here! For the seventh year running the Isle of Wight is turning pink for the whole of September! So far we have raised over £100,000 on the island to fund research, and we’d love this year to be better than ever.
Our brilliant volunteer group – Pink on Wight – are in St Thomas Square in Newport today, with entertainment, face painting and fundraising, so head down there now! And there are lots of events taking place across the island.
Here are some ways you can get involved:
From John Snow’s early investigations into cholera, Pasteur’s experiments and Koch’s postulates, we have been able to work out that germs are the root cause of many diseases. These findings quickly led to the development of preventative interventions to help reduce the
When Helpline staff talk to people calling with breast health or breast cancer questions it’s vital that the information we give is clinically accurate and of a high standard.
How does NICE decide whether to approve a new treatment?
The National Institute for Health and Care Excellence (NICE) will not recommend a drug called T-DM1 (Kadcyla) which is used to treat a type of secondary breast cancer for use on the NHS.
Rachel Rawson Clinical Nurse Specialist at Breast Cancer Care comments on research published in the journal Annals of Oncology.
The collaboration, called the international PALB2 Interest Group, have been investigating the impact of a faulty PALB2 gene on breast cancer risk. Their study, published in the New England Journal of Medicine, showed that women who carried rare mutations to the PALB2 gene were found to be more at risk of breast cancer than the general population. Importantly, the level of risk associated with these mutations was influenced by a woman’s family history of breast cancer.
What sets a scientist apart from the rest of the pack? I would suggest that timing plays a part, but I also have no doubt that you need to be innovative, diligent and dedicated to the cause in order to make the most out of the opportunities presented to you during your career.
Five UK hospitals are asking their patients with secondary breast cancer how they feel about the support and services available locally.